Literature DB >> 16918348

Cellular mechanisms and prospective applications of hypericin in photodynamic therapy.

Tobias Kiesslich1, Barbara Krammer, Kristjan Plaetzer.   

Abstract

During the last decades, Photodynamic Therapy (PDT) has been established as a powerful alternative approved by health agencies of several countries for treatment of various malignant and some non-malignant diseases. PDT makes use of the light-induced destruction of target cells by formation of cytotoxic products in the presence of a photosensitizing agent and oxygen. The light-dependent tumor destructive properties of Hypericin have drawn attention to its promising application as a photosensitizer in the frame of PDT. Hypericin is a naturally occurring secondary metabolite in plants of the Hypericum genus, with Hypericum perforatum (St. John's wort) as it is a commonly known representative. This review focuses on the cellular mechanisms of Hypericin-based phototoxicity and provides an outlook for future application of Hypericin as a fluorescing and photosensitizing agent for diagnosis and treatment of cancerous diseases, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918348     DOI: 10.2174/092986706777935267

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  16 in total

1.  Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells.

Authors:  Erin C Tracy; Mary J Bowman; Ravindra K Pandey; Barbara W Henderson; Heinz Baumann
Journal:  Photochem Photobiol       Date:  2011-10-03       Impact factor: 3.421

2.  Interaction of a Potential Anticancer Agent Hypericin and its Model Compound Emodin with DNA and Bovine Serum Albumin.

Authors:  Jana Staničová; Valéria Verebová; Jiří Beneš
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

3.  Formation of Large Hypericin Aggregates in Giant Unilamellar Vesicles-Experiments and Modeling.

Authors:  Jaroslava Joniova; Matúš Rebič; Alena Strejčková; Veronika Huntosova; Jana Staničová; Daniel Jancura; Pavol Miskovsky; Gregor Bánó
Journal:  Biophys J       Date:  2017-03-14       Impact factor: 4.033

4.  Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.

Authors:  Andrés Montoya; Alejandro Daza; Diana Muñoz; Karina Ríos; Viviana Taylor; David Cedeño; Iván D Vélez; Fernando Echeverri; Sara M Robledo
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

Review 5.  Melanoma resistance to photodynamic therapy: new insights.

Authors:  Ying-Ying Huang; Daniela Vecchio; Pinar Avci; Rui Yin; Maria Garcia-Diaz; Michael R Hamblin
Journal:  Biol Chem       Date:  2013-02       Impact factor: 3.915

6.  Photosensitizing and radiosensitizing effects of mitoxantrone: combined chemo-, photo-, and radiotherapy of DFW human melanoma cells.

Authors:  Ameneh Sazgarnia; Ali Reza Montazerabadi; Mohammad Hossein Bahreyni-Toosi; Amirhossein Ahmadi
Journal:  Lasers Med Sci       Date:  2013-02-01       Impact factor: 3.161

7.  Laser light activation of a second-generation photosensitiser and its use as a potential photomodulatory agent in skin rejuvenation.

Authors:  V Van Kets; A Karsten; L M Davids
Journal:  Lasers Med Sci       Date:  2012-05-12       Impact factor: 3.161

8.  Photosensitizer adhered to cell culture microplates induces phototoxicity in carcinoma cells.

Authors:  Verena Ziegler; Tobias Kiesslich; Barbara Krammer; Kristjan Plaetzer
Journal:  Biomed Res Int       Date:  2012-12-23       Impact factor: 3.411

9.  Hypericin-mediated photodynamic therapy induces apoptosis of myoloma SP2/0 cells depended on caspase activity in vitro.

Authors:  Junping Zhang; Linxiang Shao; Chunlin Wu; Hongfei Lu; Ruian Xu
Journal:  Cancer Cell Int       Date:  2014-12-19       Impact factor: 5.722

10.  Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.

Authors:  Bing-Qing Xu; Zi-Wei Tu; Ya-Lan Tao; Zhi-Gang Liu; Xiao-Hui Li; Wei Yi; Chang-Bing Jiang; Yun-Fei Xia
Journal:  Chin J Cancer       Date:  2016-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.